Giant Cell Arteritis

Schmidt, Dieter

doi:10.1007/978-3-540-75387-2_65

Dieter Schmidt⁶

136 Accesses

Abstract

Jonathan Hutchinson (1890) described the first patient with the characteristic signs of giant cell arteritis (GCA) and called the disease “arteritis of the aged.” Horton, Magath, and Brown (1932 and 1934) published the clinical and histological signs of the temporal artery inflammation as a clinical entity for the first time. The disease occurs much more often in Caucasians and in cool climates, compared to people from other parts such as Africa or Asia, and is much more frequent in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 299.00; Price excludes VAT (USA)

Hardcover Book: USD 379.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Anders HJ, Sigl T, Sander A et al (1999) Gadolinium contrast magnetic resonance imaging of the temporal artery in giant cell arteritis. J Rheumatol 26:2287–2288
CAS PubMed Google Scholar
Bley TA, Wieben O, Vaith P et al (2004) Magnetic resonance imaging depicts mural inflammation of the temporal artery in giant cell arteritis. Letter to the editor. Arthritis Rheum 51:1062–1063
Article CAS PubMed Google Scholar
Cohen S, Gardner F (2006) Bilateral choroidal ischemia in giant cell arteritis. Arch Ophthalmol 124:922
Article PubMed Google Scholar
Fastenberg DM, Feldon SE (1982) Reversible choroidal vascular insufficiency without infarction in temporal arteritis. Graefes Arch Clin Exp Ophthalmol 218:327–330
Article CAS PubMed Google Scholar
Hayreh SS (2000) Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet 355:1572–1573
Article CAS PubMed Google Scholar
Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520
Article CAS PubMed Google Scholar
Hayreh SS, Zimmerman B (2003) Management of giant cell arteritis. Our 27- year clinical study: new light on old controversies. Ophthalmologica 217:239–259
Article PubMed Google Scholar
Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128
Article CAS PubMed Google Scholar
Kawasaki A, Purvin V (2009) Giant cell arteritis: an updated review. Acta Ophthalmol 87:13–32
Article CAS PubMed Google Scholar
Mitomo T, Funuy T, Takahashi Y et al (1998) Giant cell arteritis and magnetic resonance angiography. Arthritis Rheum 41:1702
Article CAS PubMed Google Scholar
Nordborg E, Nordborg C (2003) Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology 42:413–421
Article CAS PubMed Google Scholar
Rajesh CV, Cole M (2000) Panuveitis as a presenting feature of giant cell arteritis. Br J Ophthalmol 84:340
CAS PubMed Google Scholar
Schmidt D (2005) Ocular ischemia syndrome – a malignant course of giant cell arteritis. Eur J Med Res 10:233–242
PubMed Google Scholar
Schmidt D (2008) The mystery of cotton-wool spots – a review of recent and historical descriptions. Eur J Med Res 13:231–266
PubMed Google Scholar
Schmidt D, Hetzel A, Reinhard M, Auw-Haedrich C (2003) Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis). Eur J Med Res 8:1–7
PubMed Google Scholar
Siatkowski RM, Gass JD, Glaser JS et al (1993) Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol 115:57–63
Article CAS PubMed Google Scholar
Weyand CM (2000) The pathogenesis of giant cell arteritis. J Rheumatol 27:517–522
CAS PubMed Google Scholar
Weyand CM, Ma-Krupa W, Pryshchep O et al (2005) Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 1062:195–208
Google Scholar
Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and Polymyalgia Rheumatica. N Engl J Med 371:50–57
Google Scholar
Yates M, Loke YK, Watts RA, MacGregor AJ (2014) Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis. Clin Rheumatol 33:227–236
Google Scholar

Download references

Author information

Authors and Affiliations

Department of Ophthalmology, University Eye Hospital, Killianstr. 5, Freiburg, 79106, Germany
Dieter Schmidt

Authors

Dieter Schmidt
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dieter Schmidt .

Editor information

Editors and Affiliations

Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany
Manfred Zierhut
Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom
Carlos Pavesio
School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan
Shigeaki Ohno
University of Belo Horizonte, Belo Horizonte, Brazil
Fernando Orefice
USC Eye Institute, University of Southern California, Los Angeles, California, USA
Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Schmidt, D. (2016). Giant Cell Arteritis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_65

Download citation

DOI: https://doi.org/10.1007/978-3-540-75387-2_65
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-75385-8
Online ISBN: 978-3-540-75387-2
eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics